382 related articles for article (PubMed ID: 20055167)
21. Antibody-drug conjugates: basic concepts, examples and future perspectives.
Casi G; Neri D
J Control Release; 2012 Jul; 161(2):422-8. PubMed ID: 22306430
[TBL] [Abstract][Full Text] [Related]
22. Antibody-drug conjugates as novel anti-cancer chemotherapeutics.
Peters C; Brown S
Biosci Rep; 2015 Jun; 35(4):. PubMed ID: 26182432
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in tumor-targeting anticancer drug conjugates.
Jaracz S; Chen J; Kuznetsova LV; Ojima I
Bioorg Med Chem; 2005 Sep; 13(17):5043-54. PubMed ID: 15955702
[TBL] [Abstract][Full Text] [Related]
24. Antibody-drug conjugates: Current status and future perspectives.
GĂ©bleux R; Casi G
Pharmacol Ther; 2016 Nov; 167():48-59. PubMed ID: 27492898
[TBL] [Abstract][Full Text] [Related]
25. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics.
Gerber HP; Koehn FE; Abraham RT
Nat Prod Rep; 2013 May; 30(5):625-39. PubMed ID: 23525375
[TBL] [Abstract][Full Text] [Related]
26. Potent antibody drug conjugates for cancer therapy.
Senter PD
Curr Opin Chem Biol; 2009 Jun; 13(3):235-44. PubMed ID: 19414278
[TBL] [Abstract][Full Text] [Related]
27. Antibody drug conjugates: the future of chemotherapy?
Borcoman E; Le Tourneau C
Curr Opin Oncol; 2016 Sep; 28(5):429-36. PubMed ID: 27366963
[TBL] [Abstract][Full Text] [Related]
28. Antibody Drug Conjugates for Cancer Therapy.
Polakis P
Pharmacol Rev; 2016 Jan; 68(1):3-19. PubMed ID: 26589413
[TBL] [Abstract][Full Text] [Related]
29. Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.
Vezina HE; Cotreau M; Han TH; Gupta M
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S11-S25. PubMed ID: 28921650
[TBL] [Abstract][Full Text] [Related]
30. Cell killing by antibody-drug conjugates.
Kovtun YV; Goldmacher VS
Cancer Lett; 2007 Oct; 255(2):232-40. PubMed ID: 17553616
[TBL] [Abstract][Full Text] [Related]
31. Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy.
Nasiri H; Valedkarimi Z; Aghebati-Maleki L; Majidi J
J Cell Physiol; 2018 Sep; 233(9):6441-6457. PubMed ID: 29319167
[TBL] [Abstract][Full Text] [Related]
32. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
33. Alphav integrin-targeted immunoconjugates regress established human tumors in xenograft models.
Chen Q; Millar HJ; McCabe FL; Manning CD; Steeves R; Lai K; Kellogg B; Lutz RJ; Trikha M; Nakada MT; Anderson GM
Clin Cancer Res; 2007 Jun; 13(12):3689-95. PubMed ID: 17575234
[TBL] [Abstract][Full Text] [Related]
34. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.
Knutson S; Raja E; Bomgarden R; Nlend M; Chen A; Kalyanasundaram R; Desai S
PLoS One; 2016; 11(6):e0157762. PubMed ID: 27336622
[TBL] [Abstract][Full Text] [Related]
35. Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
Doronina SO; Toki BE; Torgov MY; Mendelsohn BA; Cerveny CG; Chace DF; DeBlanc RL; Gearing RP; Bovee TD; Siegall CB; Francisco JA; Wahl AF; Meyer DL; Senter PD
Nat Biotechnol; 2003 Jul; 21(7):778-84. PubMed ID: 12778055
[TBL] [Abstract][Full Text] [Related]
36. [Immunoconjugates, drug-armed antibodies to fight against cancer].
Haeuw JF; Caussanel V; Beck A
Med Sci (Paris); 2009 Dec; 25(12):1046-52. PubMed ID: 20035677
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy.
Patri AK; Myc A; Beals J; Thomas TP; Bander NH; Baker JR
Bioconjug Chem; 2004; 15(6):1174-81. PubMed ID: 15546182
[TBL] [Abstract][Full Text] [Related]
39. Computational Approaches in Antibody-drug Conjugate Optimization for Targeted Cancer Therapy.
Melo R; Lemos A; Preto AJ; Almeida JG; Correia JDG; Sensoy O; Moreira IS
Curr Top Med Chem; 2018; 18(13):1091-1109. PubMed ID: 30068276
[TBL] [Abstract][Full Text] [Related]
40. Drug-conjugated monoclonal antibodies for the treatment of cancer.
Lambert JM
Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]